The chemical class known as Trimethyl Histone H3 Inhibitors encompasses a group of organic compounds that share a common mechanism of action: the modulation of trimethylation at specific lysine or arginine residues on histone H3 proteins. Histone H3 trimethylation is a crucial post-translational modification that plays a pivotal role in epigenetic regulation, affecting gene expression and chromatin structure. These inhibitors are designed to selectively target enzymes responsible for the trimethylation of histone H3, thereby altering the epigenetic landscape of chromatin. By binding to the active sites of these enzymes, the inhibitors disrupt the catalytic function necessary for the addition of trimethyl groups to specific histone residues. What sets the chemical class of Trimethyl Histone H3 Inhibitors apart is their precise chemical structures, which are tailored to interact with the active sites of specific enzymes involved in histone H3 trimethylation. Through this interaction, they hinder the enzymes' ability to carry out the trimethylation process, leading to alterations in gene expression patterns. These inhibitors often exhibit specificity for particular enzymes responsible for specific trimethylation events, such as H3K27me3, H3K4me3, H3R2me3, and others.
The discovery and utilization of Trimethyl Histone H3 Inhibitors have significantly advanced our understanding of epigenetic regulation and chromatin dynamics. Researchers employ these inhibitors as powerful tools to investigate the functional consequences of altering histone H3 trimethylation patterns on cellular processes and gene expression profiles. By selectively inhibiting specific trimethylation marks, scientists can decipher the roles of these modifications in diverse biological contexts. The chemical class of Trimethyl Histone H3 Inhibitors has enabled profound insights into the complex interplay between epigenetic modifications and chromatin-mediated control of gene expression, fostering a deeper appreciation for the intricate molecular mechanisms that shape cellular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
A potent inhibitor of histone H3 lysine 27 trimethylation (H3K27me3) catalyzed by the enzyme EZHUNC1999 has shown potential in cancer research by targeting EZH2-driven epigenetic alterations. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
Another inhibitor of EZH2, EPZ-6438 specifically targets H3K27meIt has been investigated for its therapeutic potential in certain cancers with EZH2 mutations. | ||||||
GSK343 | 1346704-33-3 | sc-397025 sc-397025A | 5 mg 25 mg | $151.00 $461.00 | 1 | |
A small molecule inhibitor that targets EZH2 and suppresses H3K27 trimethylation. GSK343 has been used to study epigenetic regulation in cellular processes and diseases. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
A selective inhibitor of the H3K9 methyltransferases G9a and GLP, which are involved in gene repression. UNC0638 has been used to study the roles of G9a and GLP in cellular processes. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
An inhibitor of G9a and GLP, BIX-01294 targets H3K9 methylation. It has been used to investigate the functions of these enzymes in various biological contexts. | ||||||
CPI-360 | 1802175-06-9 | sc-507464 | 1 mg | $100.00 | ||
This inhibitor targets both the H3K4 methyltransferase SETD1A/B and the H3K27 methyltransferase EZHIt has been explored for its potential in cancer therapy. | ||||||
SGC707 | 1687736-54-4 | sc-507461 | 1 mg | $48.00 | ||
An inhibitor of PRMT7, an enzyme responsible for H3R2 methylation. SGC707 has been used to investigate the effects of PRMT7 inhibition on cellular processes. | ||||||
AMI-1, sodium salt | 20324-87-2 | sc-205928 sc-205928A | 5 mg 25 mg | $114.00 $398.00 | 2 | |
An inhibitor of PRMT1, which catalyzes H3R2 methylation. AMI-1 has been employed to investigate the roles of PRMT1 in various cellular processes. | ||||||
MS023 | 1831110-54-3 | sc-507463 | 5 mg | $165.00 | ||
An inhibitor of PRMT1 and PRMT3, MS023 affects various histone arginine methylation marks, including those on HIt has been used to explore the functional consequences of PRMT inhibition. | ||||||